cannabis indica

Índice completo — página 45 de 77

Estudos 4.401 a 4.500 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2018. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 4.401 a 4.500

  1. 2018

    Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides

  2. 2018

    Appraising the "Entourage Effect": Antitumor Action of a Pure Cannabinoid Versus a Botanical Drug Preparation in Preclinical Models of Breast Cancer

    FavorávelEstudo em AnimaisCâncerCâncer — MamaTHC Farmacêutico
  3. 2018

    Approach bias modification for cannabis use disorder: A proof-of-principle study

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+2
  4. 2018

    Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  5. 2018

    Association between use of marijuana and time to pregnancy in men and women: findings from the National Survey of Family Growth

    InconclusivoMetanáliseInfertilidade Masculina
  6. 2018

    Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults

    InconclusivoMetanáliseEfeitos Adversos da CannabisDisfunção Cognitiva
  7. 2018

    Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men

    InconclusivoMetanáliseEfeitos Adversos da CannabisHIV/AIDS
  8. 2018

    Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer

    FavorávelMetanáliseCâncerCâncer — Escamoso de Cabeça e Pescoço
  9. 2018

    Association of Phytol With Toxic and Cytotoxic Activities in an Antitumoral Perspective: A Meta-Analysis and Systemic Review

    InconclusivoMetanáliseCâncer
  10. 2018

    Association of vascular indices with novel circulating biomarkers as prognostic factors for cardiovascular complications in patients with type 2 diabetes mellitus

  11. 2018

    Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes

    InconclusivoMetanáliseDoenças Cardiovasculares (DCV)
  12. 2018

    Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis

  13. 2018

    Bacteria colonising Penstemon digitalis show volatile and tissue-specific responses to a natural concentration range of the floral volatile linalool.

    FavorávelEstudo LaboratorialInfecções Bacterianas
  14. 2018

    Beneficial Effect of Medical Cannabis in the Treatment of a Pharmacoresistant Nausea Associated with a Somatoform Disorder in a Patient with Post-Polio Syndrome.

    FavorávelMetanáliseSíndrome Pós-Poliomielite
  15. 2018

    Betacaryophyllene – A phytocannabinoid as potential therapeutic modality for human sepsis?

    FavorávelMetanáliseSepse
  16. 2018

    Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials

  17. 2018

    Biphasic effects of THC in memory and cognition.

  18. 2018

    Borneol and Luteolin from Chrysanthemum morifolium Regulate Ubiquitin Signal Degradation

    FavorávelEstudo LaboratorialCâncer
  19. 2018

    Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors

    FavorávelEstudo LaboratorialAVC
  20. 2018

    Burden of arrhythmia in recreational marijuana users

  21. 2018

    C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaFicocianina
  22. 2018

    Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.

    FavorávelEnsaio Clínico Duplo-CegoEsquizofrenia
  23. 2018

    Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.

    FavorávelEstudo em AnimaisEsquizofrenia
  24. 2018

    Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

  25. 2018

    Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.

  26. 2018

    Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.

    FavorávelEstudo em AnimaisEfeitos Adversos da CannabisCanabinol (CBN)
  27. 2018

    Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells

    FavorávelEstudo em AnimaisEsclerose Múltipla
  28. 2018

    Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor

    FavorávelEstudo em AnimaisDorEpilepsiaAVC+1
  29. 2018

    Cannabidiol for drug-resistant seizures in the Dravet syndrome

    FavorávelEnsaio ClínicoEpilepsiaNáusea e VômitoAnorexia (perda de apetite)+2
  30. 2018

    Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

    FavorávelEnsaio Clínico Duplo-CegoEpilepsiaEpilepsia — Lennox-Gastaut
  31. 2018

    Cannabidiol in the Lennox-Gastaut Syndrome

    FavorávelMetanáliseEpilepsiaEpilepsia — Lennox-Gastaut
  32. 2018

    Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats

  33. 2018

    Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  34. 2018

    Cannabidiol prevents haloperidol-induced vacuos chewing movements and inflammatory changes in mice via PPARγ receptors

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoDistonia+1
  35. 2018

    Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia.

    FavorávelEstudo em AnimaisAVC
  36. 2018

    Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal

    FavorávelEstudo em AnimaisCanabinoides Sintéticos CP-x
  37. 2018

    Cannabidiol Regulates Long Term Potentiation Following Status Epilepticus: Mediation by Calcium Stores and Serotonin.

    FavorávelEstudo em AnimaisEpilepsia
  38. 2018

    Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.

  39. 2018

    Cannabidiol to Improve Mobility in People with Multiple Sclerosis

    FavorávelMetanáliseEsclerose Múltipla
  40. 2018

    Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Estimulantes
  41. 2018

    Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

    InconclusivoEstudo LaboratorialCanabigerol (CBG)
  42. 2018

    Cannabinoid Disposition After Human Intraperitoneal Use: AnInsight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer

    DesfavorávelMetanáliseCâncerCâncer — MetastáticoCâncer — Ovário
  43. 2018

    Cannabinoid hyperemesis syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese CanabinoideTetraidrocanabinol (THC)
  44. 2018

    Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  45. 2018

    Cannabinoid Hyperemesis Syndrome Masquerading as Uremia: An Educational Case Report.

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  46. 2018

    Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicenter retrospective chart review in a major urban area

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  47. 2018

    Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  48. 2018

    Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment

    DesfavorávelMetanáliseSíndrome da Hiperêmese CanabinoideCapsaicina (CAPS)
  49. 2018

    Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  50. 2018

    Cannabinoid pharmacology and therapy in gut disorders

    FavorávelMetanáliseCâncerNáusea e VômitoSíndrome do Intestino Irritável+1
  51. 2018

    Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review

  52. 2018

    Cannabinoid receptor types 1 and 2 and peroxisome proliferator-activated receptor-α: distribution in the skin of clinically healthy cats and cats with hypersensitivity dermatitis

    FavorávelMetanáliseAplicações Veterinárias
  53. 2018

    Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans

    DesfavorávelEnsaio Clínico Duplo-CegoDisfunção CognitivaCanabinoides Sintéticos AM-xCanabinoides Sintéticos CP-x
  54. 2018

    Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders.

  55. 2018

    Cannabinoid-induced Cell Death In Endometrial Cancer Cells: Involvement Of TRPV1 Receptors In Apoptosis

    FavorávelEstudo LaboratorialCâncerCâncer — ÚteroAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  56. 2018

    Cannabinoid-mediated retinal rescue correlates with improved circadian parameters in retinal dystrophic rats.

  57. 2018

    Cannabinoids and Gastrointestinal Motility: Pharmacology, Clinical Effects, and Potential Therapeutics in Humans

  58. 2018

    Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials.

    FavorávelMetanálise ClínicaEsclerose Múltipla
  59. 2018

    Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia

  60. 2018

    Cannabinoids for the treatment of rheumatic diseases - where do we stand?

  61. 2018

    Cannabinoids for Treatment of Dystonia in Huntington's Disease.

  62. 2018

    Cannabinoids for Treatment of MS Symptoms: State of the Evidence

    FavorávelMetanáliseEsclerose MúltiplaTetraidrocanabinol (THC)
  63. 2018

    Cannabinoids in dermatology: a scoping review.

  64. 2018

    Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation

    FavorávelMetanáliseSíndrome MetabólicaPerda de Apetite
  65. 2018

    Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.

    FavorávelEstudo em AnimaisTEPTCanabinoides Sintéticos WIN-xOutros Compostos Relacionados
  66. 2018

    Cannabinoids, the Heart of the Matter.

  67. 2018

    Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome.

    FavorávelMetanáliseTiques e Síndrome de Tourette
  68. 2018

    Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaTetraidrocanabinol (THC)
  69. 2018

    Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.

    FavorávelMetanáliseDorDor — Crônica
  70. 2018

    Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.

    FavorávelMetanáliseArtriteArtrite — Osteoartrite
  71. 2018

    Cannabis and pediatric inflammatory bowel disease: change blossoms a mile high.

  72. 2018

    Cannabis and psychosis: what do we know and what should we do?

    DesfavorávelMetanálisePsicoseCanabinoide Sintético (não especificado)
  73. 2018

    Cannabis consumption and psychosis or schizophrenia development

    DesfavorávelMetanálisePsicoseEsquizofrenia
  74. 2018

    Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoDisfunção Cognitiva+1
  75. 2018

    Cannabis for chronic pain: Not a simple solution

    InconclusivoMetanáliseDorDor — CrônicaDor — Neuropatia Periférica
  76. 2018

    Cannabis for paediatric epilepsy: challenges and conundrums

    FavorávelMetanáliseEpilepsiaEpilepsia — Síndrome de Dravet
  77. 2018

    Cannabis for peripheral neuropathy: The good, the bad, and the unknown

    FavorávelMetanáliseDorDor — Neuropatia Periférica
  78. 2018

    Cannabis for the treatment of Crohn's disease

    InconclusivoMetanáliseDII — Doença de Crohn
  79. 2018

    Cannabis for the Treatment of Epilepsy: an Update

  80. 2018

    Cannabis in Palliative Care: Current Challenges and Practical Recommendations

    FavorávelMetanáliseCuidados Paliativos
  81. 2018

    Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer

  82. 2018

    Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury

    FavorávelMetanáliseDorDor — CrônicaLesões da Medula Espinhal
  83. 2018

    Cannabis Therapeutics and the Future of Neurology

  84. 2018

    Cannabis Use During the Perinatal Period in a State With Legalized Recreational and Medical Marijuana: The Association Between Maternal Characteristics, Breastfeeding Patterns, and Neonatal Outcomes

    DesfavorávelMetanáliseGestação
  85. 2018

    Cannabis Use in Individuals With Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado

    FavorávelMetanáliseLesões da Medula EspinhalTraumatismo Cranioencefálico
  86. 2018

    Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain

    FavorávelMetanáliseDorDependência QuímicaDependência — Cannabis+6
  87. 2018

    Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.

    FavorávelMetanáliseCâncerFibroseFibrose — Hepática (Cirrose)+3
  88. 2018

    Cannabis Use, Lung Cancer, and Related Issues

    FavorávelMetanáliseDorCâncerAnsiedadeTHC Farmacêutico+4
  89. 2018

    Cannabis‐based medicines for chronic neuropathic pain in adults

    FavorávelMetanáliseDorDor — CrônicaTHC FarmacêuticoTHC:CBD Farmacêutico
  90. 2018

    Cardiovascular Complications of Marijuana and Related Substances: A Review

  91. 2018

    Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol

    FavorávelMetanáliseCâncerCâncer — Cérebro
  92. 2018

    CB1 cannabinoid receptor ligands augment the antidepressant-like activity of biometals (magnesium and zinc) in the behavioural tests.

  93. 2018

    CB1 receptors in the paraventricular nucleus of the hypothalamus modulate the release of 5-HT and GABA to stimulate food intake in rats

    FavorávelEstudo em AnimaisEndocanabinoide (não especificado)
  94. 2018

    Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders

  95. 2018

    Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults

    FavorávelMetanáliseDorAnsiedadeDepressão+2
  96. 2018

    Chromatographic Analyses, In Vitro Biological Activities, and Cytotoxicity of Cannabis sativa L. Essential Oil: A Multidisciplinary Study

    FavorávelEstudo LaboratorialCâncerInfecções BacterianasCâncer — Mama+3
  97. 2018

    Chronic cannabidiol exposure promotes functional impairment in sexual behavior and fertility of male mice.

    DesfavorávelEstudo em AnimaisLibidoDisfunção Erétil
  98. 2018

    Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay

    FavorávelEnsaio ClínicoDorInflamaçãoDor — Crônica+2
  99. 2018

    Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling.

    FavorávelEstudo em AnimaisAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  100. 2018

    Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome